FI772557A - THERE ARE ORGANIC CONTAINERS FOR FRAMSTAELLNING AND ANALYSIS - Google Patents

THERE ARE ORGANIC CONTAINERS FOR FRAMSTAELLNING AND ANALYSIS

Info

Publication number
FI772557A
FI772557A FI772557A FI772557A FI772557A FI 772557 A FI772557 A FI 772557A FI 772557 A FI772557 A FI 772557A FI 772557 A FI772557 A FI 772557A FI 772557 A FI772557 A FI 772557A
Authority
FI
Finland
Prior art keywords
framstaellning
analysis
organic containers
containers
organic
Prior art date
Application number
FI772557A
Other languages
Finnish (fi)
Other versions
FI64942C (en
FI64942B (en
Inventor
Peter Stuetz
Paul Stadler
Original Assignee
Sandoz Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from CH1128776A external-priority patent/CH623592A5/en
Priority claimed from CH1128676A external-priority patent/CH623591A5/en
Application filed by Sandoz Ag filed Critical Sandoz Ag
Publication of FI772557A publication Critical patent/FI772557A/en
Application granted granted Critical
Publication of FI64942B publication Critical patent/FI64942B/en
Publication of FI64942C publication Critical patent/FI64942C/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D519/00—Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups C07D453/00 or C07D455/00
    • C07D519/02—Ergot alkaloids of the cyclic peptide type

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Cardiology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
FI772557A 1976-09-06 1977-08-29 ANALOGIFICATION OF THE THERAPEUTIC FREQUENCY OF THERAPEUTIC 6'-DESOXO-9,10-DIHYDRO-BETA-ERGOCRYPTIN AND SALTER DAERAV FI64942C (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
CH1128676 1976-09-06
CH1128776A CH623592A5 (en) 1976-09-06 1976-09-06 Process for the preparation of ergopeptide alkaloid derivatives
CH1128776 1976-09-06
CH1128676A CH623591A5 (en) 1976-09-06 1976-09-06 Process for the preparation of ergopeptide alkaloid derivatives

Publications (3)

Publication Number Publication Date
FI772557A true FI772557A (en) 1978-03-07
FI64942B FI64942B (en) 1983-10-31
FI64942C FI64942C (en) 1984-02-10

Family

ID=25708069

Family Applications (1)

Application Number Title Priority Date Filing Date
FI772557A FI64942C (en) 1976-09-06 1977-08-29 ANALOGIFICATION OF THE THERAPEUTIC FREQUENCY OF THERAPEUTIC 6'-DESOXO-9,10-DIHYDRO-BETA-ERGOCRYPTIN AND SALTER DAERAV

Country Status (15)

Country Link
JP (1) JPS5331698A (en)
AU (1) AU512027B2 (en)
CA (1) CA1105007A (en)
DE (1) DE2738730A1 (en)
DK (1) DK147390C (en)
ES (1) ES462080A1 (en)
FI (1) FI64942C (en)
FR (1) FR2363571A1 (en)
GB (2) GB1590150A (en)
IE (1) IE46152B1 (en)
IL (1) IL52896A (en)
NL (1) NL7709683A (en)
NZ (1) NZ185098A (en)
PT (1) PT67003B (en)
SE (1) SE435839B (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR112013033339A2 (en) * 2011-06-23 2016-08-16 Map Pharmaceuticals Inc fluorergoline analogs

Also Published As

Publication number Publication date
GB1590149A (en) 1981-05-28
DK382777A (en) 1978-03-07
ES462080A1 (en) 1978-12-01
CA1105007A (en) 1981-07-14
IL52896A (en) 1980-07-31
NZ185098A (en) 1980-04-28
PT67003A (en) 1977-10-01
FI64942C (en) 1984-02-10
IL52896A0 (en) 1977-11-30
SE435839B (en) 1984-10-22
AU2857277A (en) 1979-03-15
FR2363571A1 (en) 1978-03-31
DK147390C (en) 1985-02-04
SE7709645L (en) 1978-03-07
DK147390B (en) 1984-07-16
NL7709683A (en) 1978-03-08
PT67003B (en) 1979-05-14
IE46152B1 (en) 1983-03-09
JPS5331698A (en) 1978-03-25
FI64942B (en) 1983-10-31
IE46152L (en) 1978-03-06
FR2363571B1 (en) 1980-04-18
GB1590150A (en) 1981-05-28
DE2738730A1 (en) 1978-03-16
AU512027B2 (en) 1980-09-18

Similar Documents

Publication Publication Date Title
FI773595A (en) THERE ARE ORGANIC CONTAINERS FOR FRAMSTAELLNING AND ANALYSIS
FI803042A (en) NYA NAPHTHYRIDINDERIVAT OCH FOERFARANDE FOER DERAS FRAMSTAELLNING
FI802876A (en) NYA BIOLOGISKT AKTIVA PEPTIDER OCH FOERFARANDE FOER FRAMSTAELLNING DAERAV
FI772823A (en) NYA 1-ARYLOXI-HYDROXI-3-ALKYLENAMINOPROPANER OCH FOERFARANDE FOER DERAS FRAMSTAELLNING
FI801640A (en) NYA TIOVINYL-3 KEFALOSPORINER DERAS FRAMSTAELLNING OCH DESSA INNEHAOLLANDE KOMPOSITIONER
FI773804A (en) NYA NUCLEOSIDER OCH FOERFARANDE FOER DERAS FRAMSTAELLNING
FI800024A (en) NYA PLEUROMUTILINDERIVAT DERAS FRAMSTAELLNING OCH ANVAENDNING
FI772262A (en) NYA FENYLETYLAMINER OCH FOERFARANDE FOER DERAS FRAMSTAELLNING
SE425190B (en) microtome
FI802228A (en) NYA KARBOXYLSYRADERIVATER DERAS FRAMSTAELLNING OCH DERAS ANVAENDNING
SE7812911L (en) NEW ORGANIC ASSOCIATIONS
FI772594A (en) NEW FRAMEWORK FOR FRAMEWORK
FI773273A (en) THERE ARE ORGANIC CONTAINERS FOR FRAMSTAELLNING AND ANALYSIS
FI780029A (en) THERE ARE ORGANIC FACILITIES FOR FRAMSTAELLNING AND ANALYSIS
FI801757A (en) NYA HYDROXIAMINO-EBURNANDERIVAT OCH FOERFARANDE FOER DERAS FRAMSTAELLNING
FI780168A (en) THERE ARE ORGANIC FACILITIES FOR FRAMSTAELLNING AND ANALYSIS
FI780130A (en) THERE ARE ORGANIC FACILITIES FOR FRAMSTAELLNING AND ANALYSIS
FI772955A (en) THERE ARE ORGANIC FACILITIES FOR FRAMSTAELLNING AND ANALYSIS
FI781520A (en) THERE ARE ORGANIC FACILITIES FOR FRAMSTAELLNING AND ANALYSIS
FI800132A (en) NYA KEFALOSPORINDERIVAT DERAS FRAMSTAELLNING OCH ANVAENDNING
FI780835A (en) THERE ARE ORGANIC FACILITIES FOR FRAMSTAELLNING AND ANALYSIS
FI772557A (en) THERE ARE ORGANIC CONTAINERS FOR FRAMSTAELLNING AND ANALYSIS
FI772758A (en) HATEROCYCLISM FOR THE FRAMEWORK
FI773688A (en) THERE ARE ORGANIC FACILITIES FOR FRAMSTAELLNING AND ANALYSIS
FI772695A (en) ORGANIC FOERENINGAR DERAS ANVAENDNING OCH FRAMSTAELLNING

Legal Events

Date Code Title Description
MM Patent lapsed

Owner name: SANDOZ AG